(Q34729463)

4 August 2017

title

Prothymosin alpha enhances interleukin 2 receptor expression in normal human T-lymphocytes (English)

1 reference

4 August 2017

Prothymosin α enhances interleukin 2 receptor expression in normal human T-lymphocytes (English)

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

1 December 2022

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

1 December 2022

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

1 December 2022

1

O. J. Cordero

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1814846

1 December 2022

5

B. J. Regueiro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1814846

1 December 2022

author name string

C. S. Sarandeses

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1814846

1 December 2022

J. L. López

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1814846

1 December 2022

E. Cancio

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1814846

1 December 2022

M. Nogueira

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1814846

1 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1814846

1 December 2022

publication date

1 January 1991

1 reference

full work available at URL

4 August 2017

https://api.elsevier.com/content/article/PII:0192056191901562?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

https://api.elsevier.com/content/article/PII:0192056191901562?httpAccept=text/plain

1 December 2022

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

International Journal of Immunopharmacology

1 December 2022

published in

1 reference

4 August 2017

volume

13

1 reference

4 August 2017

issue

8

1 reference

4 August 2017

page(s)

1059-1065

1 reference

Long term culture of tumour-specific cytotoxic T cells

4 August 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/268154A0

Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene

2

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

Long-term culture of human antigen-specific cytotoxic T-cell lines

1 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

Augmentation of influenza antibody response in elderly men by thymosin alpha one. A double-blind placebo-controlled clinical study

1 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

Interleukin-2 augments natural killer cell activity

1 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription

1 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

Characterization of the immunoregulatory properties of thymosin alpha 1 on interleukin-2 production and interleukin-2 receptor expression in normal human lymphocytes.

1 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

1 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

In vitro immunomodulatory effects of interleukin-2 and thymosin fraction V in acquired immune deficiency syndrome

1 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen

1 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

Thymic hormones--a clinical update

1 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

Characterization of the immunoregulatory properties of thymosin alpha 1 on interleukin-2 production and interleukin-2 receptor expression in normal human lymphocytes.

1 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

Interleukin 1 and protein kinase C activator are dissimilar in their effects on Il-2 receptor expression and Il-2 secretion by T lymphocytes

1 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphocytes

1 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

Continuous culture of T cells cytotoxic for autologous human leukaemia cells

1 December 2022

26

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

Thymosin increases production of T-cell growth factor by normal human peripheral blood lymphocytes

1 December 2022

27

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

Comparison of the effects of thymosin and other thymic factors on modulation of interleukin-2 production

1 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90156-2

1 December 2022

Identifiers

1 reference

4 August 2017

1 reference